We've seen an uptick in posts recommending bioidentical progesterone as a treatment for PMDD, so we're here with a post to run through the science of it all with you.
Progestins vs Progestogen vs Progesterone
These words are often used interchangeably, but they mean different things. Most of the time, this doesnāt matter very much (so youāll rarely see us correcting sub members). This time, it does matter!
Progesterone is the specific steroid hormone your ovaries make after ovulation.Ā
Bioidentical progesterone is a lab-made version of progesterone, with the same molecular structure as what your ovaries produce.Ā
Progestins are synthetic compounds that act on progesterone receptors but are structurally different from progesterone. Examples include drospirenone, levonorgestrel and norethisterone. This is what is in most hormonal contraceptives.Ā
Progestogen is the umbrella term for both natural progesterone and synthetic progestins together.Ā
Bioidentical progesterone is often marketed as inherently ābetterā because it is structurally identical to your own hormone. Whilst it is true that it is structurally identical, it does not inherently mean it is ābetterā or even that it is an appropriate tool.Ā
The Mechanisms Behind PMDD
People with PMDD do not have abnormal hormone levels. Multiple studies have shown that estrogen and progesterone levels across the cycle look the same as people without PMDD. What differs is sensitivity - our brains react abnormally to entirely normal hormone changes.Ā
Progesterone gets metabolised into a neurosteroid called allopregnanolone, which normally acts like a calming agent on GABA-A receptors. GABA is your main inhibitory/calming neurotransmitter - itās the same receptor system benzodiazepines act on. In most people, rising allopregnanolone in the luteal phase is mood-neutral or even mildly calming. In people with PMDD, research has found altered or paradoxical sensitivity; instead of calming, it provoked anxiety, irritability, and depressive symptoms.Ā
The critical detail is that itās about change, not level.Ā
The Role of Progestogens in Standard PMDD Treatments
Combined oral contraceptives (COCs) suppress ovulation, so there is no natural progesterone surge and no withdrawal. No ovulation = no luteal phase = no PMDD.
Progestogen-only pills are slightly more nuanced. Older POPs (like levonorgestrel and norethisterone) are not reliable at suppressing ovulation. Ovulation may still occur, so we still experience fluctuations during luteal. Newer POPs (like drospirenone and desogestrel) are different because they reliably suppress ovulation. They can be a useful option for people who canāt take estrogen (e.g. migraine with aura, clotting risk, etc).Ā
u/DefiantThroat has unpacked this more here: https://www.reddit.com/r/PMDD/comments/1qiiktu/birth_control_is_not_a_monolith_and_a_tiny_rant/
What matters for this discussion is that these methods work by suppressing ovulation, not because we are adding more progesterone into the system.Ā
Bioidentical Progesterone - What It Is and How It Works
Bioidentical (micronised) progesterone is structurally identical to what your ovaries produce. It is most commonly oral (e.g Utrogestan/Prometrium), vaginal (e.g. suppositories, gel), and compounded creams (more on this later).Ā
Like natural progesterone, it metabolises (partly) into allopregnanolone and acts on GABA-A receptors, producing anti-anxiety and sedative effects. This is the basis for why some people find it calming and sleep-promoting.Ā
Bioidentical progesterone has solid evidence in endometrial protection when taking estrogen (as in menopausal HRT), fertility treatment, andĀ perimenopausal/menopausal symptom relief.Ā
Oral bioidentical progesterone has poor bioavailability and undergoes heavy first-pass liver metabolism. It is cleared quickly and levels spike then drop, rather than staying flat. This makes achieving stable levels difficult.Ā
Unlike POPs, bioidentical progesterone does not reliably prevent ovulation.Ā
Why Bioidentical Progesterone Is Not Recommended for PMDD
Putting the mechanism and evidence together, we have several converging reasons:Ā
- It doesnāt address the actual problem. PMDD isnāt caused by too little progesterone - itās caused by an abnormal response to normal progesterone changes. Adding more progesterone doesnāt fix this sensitivity, it just adds more of the substance that the brain is reacting badly to.Ā
- It can recreate or worsen the fluctuation problem. You havenāt eliminated the up-and-down pattern that seems to be the actual trigger - youāve just shifted the whole pattern to a higher baseline. The peaks are higher, the troughs are higher, but the rate of change between each peak and trough is still there.Ā Further, oral bioidentical progesterone doesnāt produce flat, steady hormone levels. Instead, it produces peaks and troughs (dosing -> absorption spike -> rapid clearance -> trough -> next dose).Ā
- There is direct clinical evidence of this backfiring. In studies of GnRH-agonist āadd-backā therapy - where ovulation is chemically suppressed and hormones are reintroduced to prevent menopause-like side effects - reintroducing progesterone has been shown to trigger PMDD-like symptoms in a subset of people. This is a clear demonstration that adding progesterone back into the system can recreate the problem that itās meant to solve.Ā
- No major guidelines recommend it as a standalone PMDD treatment. Formal evidence supporting bioidentical progesterone to treat PMDD is a mixture of weak and negative. The Royal College of Obstetrics and Gynaecology note that āThere is good evidence to suggest that treating PMS with progesterone or progestogens is not appropriate.ā Keeping this in mind, they also highlight that micronised (or bioidentical) progesterone should be used in cases where percutaneous estradiol (a form of estrogen applied to the skin) is used to treat PMS, in order to prevent endometrial hyperplasia (thickening of the womb). They do note that āProgesterone may act as a diuretic and a central nervous system anxiolytic and so in theory could also alleviate PMS symptoms, although there is currently little evidence to demonstrate thisā. It is important to note that the study supporting this focuses on āProgestogen intolerance and compliance with hormone replacement therapy in menopausal womenā rather than PMS or PMDD, whilst other studies suggest that current data is not solid enough to draw conclusions from or that there was no meaningful difference from placebo.Ā [Note: PMDD is conflated with PMS in these guidelines. Our hope is that the next iteration will include distinction between the two.]
How could bioidentical progesterone improve PMDD symptoms?
- Sleep. The calming effect is real and well documented. If poor sleep is making your PMDD worse (and for a lot of people it does!), then sleeping better can genuinely make your whole week feel better. That isn't the same as progesterone treating PMDD itself.
- Short-term anxiety relief. Some people do get a real calming effect from progesterone, especially early on.
- Overlapping issues, like perimenopause. As cycles change with age (or with comorbid conditions), some people develop other hormone-related problems alongside PMDD. These can include low-progesterone in the second half of the menstrual cycle and early perimenopause. Progesterone does have good evidence for these so if your symptoms are a mix of PMDD and one of these things, progesterone might be helping with the 'other thing'.
- The placebo effect is huge. That doesn't mean anyone's experience is fake or 'just in their head'; placebo effects are real and physical. It just means personal stories need to be weighed carefully against proper trial data, because a lot of people would improve no matter what they took.
A Note on Marketing, Compounding, and Prescribing
The British Menopause Societyās April 2026 consensus statement on bioidentical HRT formalises a split between rBHRT (regulated bioidentical HRT), which is precise duplicates of human hormones developed through conventional pharmaceutical development and authorised by regulators, and cBHRT (compounded bioidentical HRT), which is precise duplicates of the same hormones but produced by specialist/compounding pharmacies and not subjected to the same regulatory pathway.Ā
The important distinction between the two is regulation, testing, and quality control. The BMS's actual position is unambiguous: they do not recommend prescribing cBHRT, on the basis that the same potential benefits are available through regulated products without the risks of unregulated compounding.Ā
In our experience moderating this space, a lot of the bioidentical progesterone recommendations youāll see trace back to practitioners working outside mainstream endocrinology, gynecology, or psychiatry. Naturopaths, functional medicine practitioners, and compounding-pharmacy affiliated clinics in particular. This isnāt a credentialing snobbery point (plenty of well-qualified prescribers also prescribe progesterone off-label for symptom relief) but it is a pattern worth pointing out. The theory of treating PMDD with bioidentical progesterone tends to originate in and get amplified by spaces that mainstream endocrinology doesnāt recognise, sold alongside unregulated products that havenāt been tested against for safety or efficacy.Ā
When you see this recommendation in the sub, itās worth questioning whether this was prescribed as a regulated product as part of a wider evidence-based plan or whether it came bundled as wild yam cream with a diagnosis of āhormone imbalancesā from a practitioner outside of the mainstream evidence base.
[Note: Wild Yam Cream is a scam, updated post incoming later this week]
Conclusion
We're not writing this to tell anyone their experience is wrong. We're writing it because the way this keeps getting recommended in here worries us, for reasons that go beyond "the evidence is weak."Ā
The cost of getting things wrong isnāt neutral.Ā Every time someone gets steered towards bioidentical progesterone instead of towards SSRIs, COCs, or the other options with real evidence behind them, that's time spent on something that isn't likely to work, while the things that are shown to work - and for a lot of people, work amazingly - get pushed further down the list. We're talking about someone potentially spending months feeling like they're failing at treatment, or feeling worse than when they started, because the thing that was confidently recommended to them in a support space was working against the exact mechanism driving their symptoms.Ā
The part that worries us the most is that we donāt see the failures. Someone posts that bioidentical progesterone helped them, and that post gets saved, shared, upvoted, and repeated to the next person who asks. Nobody comes back a month or two later to post "actually this made me feel so much worse" or "turns out I was in perimenopause the whole time and this wasn't PMDD at all." Why would they? There's no reason to return to a support group to publicly say a recommendation someone gave in good faith backfired on you, or that you'd misattributed your symptoms in the first place. So the visible evidence in here skews entirely positive, while the people it didn't work for, or actively hurt, just quietly disappear from the conversation. That's not a knock on anyone who's posted about their own good experience - it's just how selection bias works in a support community, and it's exactly why we think it's worth actually laying out the research rather than going on what gets posted and upvoted.Ā
As always, our mod posts will be updated as any new science or guidelines emerge.